UMIN ID: UMIN000054613
Registered date:09/06/2024
Analysis of blood concentration of hydroxychloroquine to predict its efficacy and safety to treat Japanese patients with rheumatoid arthritis.
Basic Information
| Recruitment status | Complete: follow-up continuing |
|---|---|
| Health condition(s) or Problem(s) studied | Rheumatoid arthritis |
| Date of first enrollment | 2023/06/27 |
| Target sample size | 60 |
| Countries of recruitment | Japan |
| Study type | Others,meta-analysis etc |
| Intervention(s) |
Outcome(s)
| Primary Outcome | association between efficacy and safety of HCQ and its blood concentration |
|---|---|
| Secondary Outcome | N.A. |
Key inclusion & exclusion criteria
| Age minimum | 18years-old |
|---|---|
| Age maximum | 100years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | Ineligible for the study judged by physicians |
Related Information
| Primary Sponsor | Keio University School of medicine |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Nothing |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Yuko Kaneko |
| Address | 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan Japan 160-8582 |
| Telephone | 03-5363-3786 |
| ykaneko.z6@keio.jp | |
| Affiliation | Keio University School of Medicine Division of Rheumatology |
| scientific contact | |
| Name | Yuko Kaneko |
| Address | 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan Japan |
| Telephone | 03-5363-3786 |
| ykaneko.z6@keio.jp | |
| Affiliation | Keio University School of medicine Division of Rheumatology |